One in two women likely to be anaemic in India, reveals study
A comprehensive study done by Metropolis Healthcare, one of India’s leading pathology labs, has revealed that over 50 per cent […]
Say something
Taking Indian Healthcare to the World
With 35 years of experience in delivering accurate reports, Metropolis has earned the reputation of being Indias leading and only […]
Lead Poisoning: A threat to Next Generation
Lead poisoning remains one of the most important environmental health concerns globally. Lead exposure is estimated to account for 143,000 […]
Survey reveals common diseases affecting Indias women population
ENN (Elets News Network) A survey conducted by Metropolis Healthcare Ltd, Indias leading multinational chain of 105 diagnostic centers and […]
Metropolis Healthcare to open 10 diagnostic labs in Gujarat
Mumbai-based diagnostic laboratory chain Metropolis Healthcare Ltd is planning to set up 10 laboratories in Gujarat over the next two […]
HEALTH FOR ALL : June 2010
EDITORIAL Public Health Par Excellence COVER STORY Health for All How TNHSP is helping the Tamil Nadu government make its health services […]
Metropolis develops screening test to predict genetic predisposition to baldness
Metropolis Healthcare Ltd, India’s only multi-national chain of diagnostics centre, has developed a screening test to predict whether an individual is genetically predisposed to hereditary male and female pattern baldness.
Focussing more on Reaserch and development to make services competitive and affordable : Ameera Patel, Metropolis Healthcare Ltd
As one of the leaders in corporate chains of diagnostic laboratories in India, Metropolis Healthcare marks its presence with great value and trust in pathological testing. Backed by strong technological support, the company is offering the best of the services and focussing into research and development.
-
-
Flipkart Health+ App Launched
06-04-2022
